Caroline Hasselbalch Riley

Medicine & Life Sciences

1. Polycythemia Vera 100%
2. Primary Myelofibrosis 93%
3. Essential Thrombocythemia 82%
4. Interferons 54%
5. Neoplasms 35%
6. T-Lymphocytes 28%
7. Calreticulin 26%
8. Genes 23%
9. Mutation 23%
10. Gene Expression Profiling 20%
11. Exons 20%
12. Interferon-alpha 18%
13. HLA Antigens 17%
14. Janus Kinase 2 16%
15. Natural Killer Cells 14%
16. MHC Class I Genes 13%
17. Down-Regulation 13%
18. MHC Class II Genes 12%
19. Therapeutics 12%
20. INCB018424 12%
21. Alleles 11%
22. Residual Neoplasm 11%
23. Regulatory T-Lymphocytes 10%
24. Arginase 10%
25. Inflammation 9%
26. Carcinoembryonic Antigen 9%
27. Cell Adhesion Molecules 8%
28. Genomic Instability 8%
29. Principal Component Analysis 8%
30. Phenotype 7%
31. B-Lymphocytes 7%
32. Blood Cells 7%
33. Real-Time Polymerase Chain Reaction 7%
34. Dendritic Cells 7%
35. Hematopoietic Stem Cells 6%
36. Disease Progression 6%
37. Oxidative Stress 5%
38. Granulocytes 5%
39. Tissue Donors 5%
40. Ligands 5%
41. Clonal Evolution 5%
42. Bone Marrow 5%